Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322 | ISIN: INE03Q201024 | Industry: Pharmaceuticals
| Mid-range Performer
915.5500 4.75 (0.52%)
NSE Dec 16, 2025 10:40 AM
Volume: 18,270
 

logo
Alivus Life Sciences Ltd.
29 Apr 2023
915.55
0.52%
buy
by BOB Capital Markets Ltd.
Target: 600
BOB Capital Markets Ltd.
Q4 revenue of Rs 6.2bn (+21% YoY) beat our estimate by 14% driven by recovery in CDMO and growth in API
 
Alivus Life Sciences Ltd. is trading below its 100 day SMA of 937.4
More from Alivus Life Sciences Ltd.
Recommended
Market trades lower, Ion Exchange secures orders worth Rs 205 cr
Trendlyne Marketwatch | 16 Dec 2025, 10:21AM
Riding the IPO wave: 10 companies to debut after 16 recent listings
| 15 Dec 2025, 04:55PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
| 27 Jul 2021